Investing.com - Tarsus reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Tarsus announced earnings per share of $-0.84 on revenue of $5M. Analysts polled by Investing.com anticipated EPS of $-0.95 on revenue of $3.13M.
Tarsus shares are down 0.45% from the beginning of the year , still down 36.42% from its 52 week high of $28.25 set on Thursday, November 11, 2021.
Tarsus shares lost 0.44% in intra-day trade the report.
Tarsus follows other major Healthcare sector earnings this month
Tarsus's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar